NIDR Supports New Research Pathways

AUTHOR: KAREN YOUNG KREEGER, pp.14 Date: May 16,1994 Arthritis, AIDS, and signal transduction may not be areas of investigation that immediately come to mind when one thinks of dental research. But the National Institute of Dental Research's (NIDR) range of interests and achievement has in recent years broadened well beyond the institute's original 1948 mandate to improve the oral health of the American people. In 1948, a congre

Written byKaren Kreeger
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


AUTHOR: KAREN YOUNG KREEGER, pp.14 Date: May 16,1994

Arthritis, AIDS, and signal transduction may not be areas of investigation that immediately come to mind when one thinks of dental research. But the National Institute of Dental Research's (NIDR) range of interests and achievement has in recent years broadened well beyond the institute's original 1948 mandate to improve the oral health of the American people.

In 1948, a congressional mandate set up the National Institute of Dental Research (NIDR), the third-oldest of the National Institutes of Health, to "address the then deplorable state of oral health in the United States," according to the institute. NIDR, which today covers 19 areas of research--including such diverse investigations as craniofacial disorders and salivary gland physiology, as well as the traditional areas of periodontal disease and tooth decay--funds both intramural and extramural projects. Some current NIDR statistics: NIDR's budget for fiscal year 1994 is $169.5 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies